MustGrow Biologics Corp.

DB:0C0 Stock Report

Market Cap: €41.9m

MustGrow Biologics Management

Management criteria checks 3/4

MustGrow Biologics' CEO is Corey Giasson, appointed in Mar 2018, has a tenure of 6.75 years. total yearly compensation is CA$302.40K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 2.24% of the company’s shares, worth €940.18K. The average tenure of the management team and the board of directors is 6.3 years and 6.6 years respectively.

Key information

Corey Giasson

Chief executive officer

CA$302.4k

Total compensation

CEO salary percentage100.0%
CEO tenure6.8yrs
CEO ownership2.2%
Management average tenure6.3yrs
Board average tenure6.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Corey Giasson's remuneration changed compared to MustGrow Biologics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-CA$245k

Jun 30 2024n/an/a

-CA$424k

Mar 31 2024n/an/a

-CA$665k

Dec 31 2023CA$302kCA$302k

-CA$677k

Sep 30 2023n/an/a

-CA$5m

Jun 30 2023n/an/a

-CA$5m

Mar 31 2023n/an/a

-CA$6m

Dec 31 2022CA$288kCA$288k

-CA$6m

Sep 30 2022n/an/a

-CA$6m

Jun 30 2022n/an/a

-CA$4m

Mar 31 2022n/an/a

-CA$3m

Dec 31 2021CA$266kCA$216k

-CA$3m

Sep 30 2021n/an/a

-CA$3m

Jun 30 2021n/an/a

-CA$3m

Mar 31 2021n/an/a

-CA$3m

Dec 31 2020CA$266kCA$216k

-CA$3m

Sep 30 2020n/an/a

-CA$3m

Jun 30 2020n/an/a

-CA$3m

Mar 31 2020n/an/a

-CA$2m

Dec 31 2019CA$148kCA$148k

-CA$2m

Sep 30 2019n/an/a

-CA$1m

Jun 30 2019n/an/a

-CA$1m

Mar 31 2019n/an/a

-CA$965k

Dec 31 2018CA$128kCA$128k

-CA$2m

Compensation vs Market: Corey's total compensation ($USD210.71K) is below average for companies of similar size in the German market ($USD468.04K).

Compensation vs Earnings: Corey's compensation has increased whilst the company is unprofitable.

CEO

Corey Giasson (46 yo)

6.8yrs

Tenure

CA$302,400

Compensation

Mr. Corey J. Giasson, MBA, B.Sc., serves as President at MustGrow Biologics Corp. and serves as its Chief Executive Officer and Director since March 15, 2018. Mr. Giasson had been the Chief Financial Offic...

Leadership Team

NamePositionTenureCompensationOwnership
Corey Giasson
President6.8yrsCA$302.40k2.24%
€ 940.2k
Todd Lahti
CFO & Corporate Secretary6yrsCA$277.20k2.07%
€ 864.9k
Colin Bletsky
COO & Director6.3yrsCA$289.80k3.41%
€ 1.4m

6.3yrs

Average Tenure

Experienced Management: 0C0's management team is seasoned and experienced (6.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Corey Giasson
President6.8yrsCA$302.40k2.24%
€ 940.2k
Colin Bletsky
COO & Director6.8yrsCA$289.80k3.41%
€ 1.4m
Bradley Munro
Independent Chairman of the Board6.8yrsno data1.86%
€ 777.5k
David Borecky
Independent Director4yrsno datano data
Matt Kowalski
Independent Director6.6yrsno data0.40%
€ 165.5k
Laura Westby
Independent Director2.8yrsno datano data
Thomas Flow
Independent Director6.6yrsno data0.52%
€ 215.9k

6.6yrs

Average Tenure

46yo

Average Age

Experienced Board: 0C0's board of directors are considered experienced (6.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 15:00
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MustGrow Biologics Corp. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph GomesNOBLE Capital Markets, Inc.